The Role of Human Endogenous Retroviruses in Cancer Immunotherapy of the Post-COVID-19 World

Stella Logotheti; Thorsten Stiewe; Alexandros G Georgakilas

doi:10.3390/cancers15225321

The Role of Human Endogenous Retroviruses in Cancer Immunotherapy of the Post-COVID-19 World

Cancers (Basel). 2023 Nov 7;15(22):5321. doi: 10.3390/cancers15225321.

Authors

Stella Logotheti¹, Thorsten Stiewe^{2

3

4

5}, Alexandros G Georgakilas¹

Affiliations

¹ DNA Damage Laboratory, Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Zografou, 15780 Athens, Greece.
² Institute of Molecular Oncology, Philipps-University, 35043 Marburg, Germany.
³ German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC), 35043 Marburg, Germany.
⁴ Genomics Core Facility, Philipps-University, 35043 Marburg, Germany.
⁵ Institute for Lung Health (ILH), Justus Liebig University, 35392 Giessen, Germany.

Abstract

At the outbreak of the COVID-19 global crisis, diverse scientific groups suggested that this unprecedented emergency could act as a 'blessing in disguise' [...].

Publication types

Editorial

Grants and funding

A.G.G. acknowledges project 21GRD02 BIOSPHERE that has received funding from the European Partnership on Metrology, co-financed by the European Union’s Horizon Europe Research and Innovation Programme and by the Participating States, and the contribution of the COST Action CA21169 ‘DYNALIFE’ supported by COST (European Cooperation in Science and Technology). T.S. acknowledges funding from Deutsche Forschungsgemeinschaft (DFG, German Research Foundation—STI182/13-1, STI182/15-1, GRK2573) and German Center for Lung Research (DZL), and Hessisches Ministerium für Wissenschaft und Kunst (LOEWE iCANx).